Waters Parkerson & Co’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.03M | Buy |
12,070
+667
| +6% | +$65.3K | 0.05% | 103 |
|
|
2026
Q2 | $1.18M | Buy |
11,403
+3
| +0% | +$268 | 0.06% | 101 |
|
|
2026
Q1 | $819K | Buy |
11,400
+100
| +0.9% | +$7.7K | 0.04% | 108 |
|
|
2025
Q4 | $897K | Hold |
11,300
| – | – | 0.04% | 105 |
|
|
2025
Q3 | $852K | Sell |
11,300
-85
| -0.7% | -$5.82K | 0.04% | 107 |
|
|
2025
Q2 | $785K | Sell |
11,385
-1,027
| -8% | -$67.3K | 0.04% | 111 |
|
|
2025
Q1 | $841K | Sell |
12,412
-329
| -3% | -$19.7K | 0.04% | 105 |
|
|
2024
Q4 | $572K | Sell |
12,741
-133,082
| -91% | -$7.47M | 0.03% | 127 |
|
|
2024
Q3 | $9.17M | Sell |
145,823
-258,803
| -64% | -$15.1M | 0.47% | 52 |
|
|
2024
Q2 | $23.9M | Sell |
404,626
-20,203
| -5% | -$1.26M | 1.27% | 30 |
|
|
2024
Q1 | $33.9M | Sell |
424,829
-2,078
| -0.5% | -$159K | 1.74% | 21 |
|
|
2023
Q4 | $33.7M | Sell |
426,907
-9,052
| -2% | -$644K | 1.87% | 18 |
|
|
2023
Q3 | $30.4M | Buy |
435,959
+11,516
| +3% | +$816K | 1.82% | 21 |
|
|
2023
Q2 | $29.3M | Buy |
424,443
+8,130
| +2% | +$578K | 1.66% | 23 |
|
|
2023
Q1 | $30.9M | Buy |
416,313
+6,708
| +2% | +$562K | 1.83% | 19 |
|
|
2022
Q4 | $38.2M | Sell |
409,605
-2,130
| -0.5% | -$206K | 2.3% | 13 |
|
|
2022
Q3 | $39.3M | Sell |
411,735
-720
| -0.2% | -$71.3K | 2.63% | 9 |
|
|
2022
Q2 | $38.2M | Buy |
412,455
+4,979
| +1% | +$486K | 2.41% | 9 |
|
|
2022
Q1 | $41.2M | Buy |
407,476
+6,448
| +2% | +$677K | 2.3% | 12 |
|
|
2021
Q4 | $41.4M | Sell |
401,028
-9,470
| -2% | -$875K | 2.18% | 14 |
|
|
2021
Q3 | $34.8M | Sell |
410,498
-512
| -0.1% | -$42.9K | 2.01% | 16 |
|
|
2021
Q2 | $34.3M | Buy |
411,010
+2,923
| +0.7% | +$239K | 1.98% | 16 |
|
|
2021
Q1 | $30.7M | Buy |
408,087
+11,661
| +3% | +$849K | 1.89% | 17 |
|
|
2020
Q4 | $27.1M | Buy |
396,426
+14,391
| +4% | +$936K | 1.81% | 17 |
|
|
2020
Q3 | $22.3M | Buy |
382,035
+1,776
| +0.5% | +$111K | 1.68% | 21 |
|
|
2020
Q2 | $24.7M | Buy |
380,259
+1,133
| +0.3% | +$71.3K | 2% | 15 |
|
|
2020
Q1 | $22.5M | Buy |
379,126
+19,122
| +5% | +$1.28M | 2.18% | 16 |
|
|
2019
Q4 | $26.7M | Buy |
360,004
+10,015
| +3% | +$703K | 2% | 19 |
|
|
2019
Q3 | $22.1M | Buy |
349,989
+20,235
| +6% | +$1.2M | 1.78% | 22 |
|
|
2019
Q2 | $18M | Buy |
329,754
+57,475
| +21% | +$3.1M | 1.46% | 27 |
|
|
2019
Q1 | $14.7M | Buy |
+272,279
| New | +$16.8M | 1.23% | 30 |
|
Other funds holding CVS
Waters Parkerson & Co's CVS Position: Q3 2026 in Review
Waters Parkerson & Co increased its CVS Health (CVS) stake by 5.8% in Q3 2026, buying an estimated $65.3K and bringing the position to 12,070 shares worth $1.03M. The position accounts for 0.05% of the portfolio, ranked #103.
Waters Parkerson & Co first reported a position in CVS in Q1 2019 and has held it in 31 quarters since. The position peaked at $41.4M in Q4 2021. 1,994 funds tracked by Wall St. Rank hold CVS as of Q3 2026.
- Waters Parkerson & Co held 12,070 shares of CVS Health worth $1.03M as of Q3 2026.
- Waters Parkerson & Co bought 667 CVS Health shares in Q3 2026, an estimated $65.3K.
- CVS Health made up 0.05% of Waters Parkerson & Co's portfolio in Q3 2026, its #103 holding.
- Waters Parkerson & Co first reported a position in CVS Health in Q1 2019 and has held it in 31 quarters since.
- Waters Parkerson & Co's CVS Health position peaked at $41.4M in Q4 2021.
- 1,994 funds tracked by Wall St. Rank held CVS Health as of Q3 2026.
Based on Waters Parkerson & Co's 13F filing for Q3 2026, filed 4 Nov 2026.